Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Biofrontera AG (NASDAQ: BFRA).

Full DD Report for BFRA

You must become a subscriber to view this report.


Recent News from (NASDAQ: BFRA)

Biofrontera Announces Conference Call to Discuss Q3 2018 Financial Results
Leverkusen, Germany, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its financial results for the 9-month period ended September 30, 2018 on November ...
Source: GlobeNewswire
Date: November, 05 2018 06:26
Biofrontera (BFRA) Presents At DAWSON JAMES 4th Annual Small Cap Growth Conference - Slideshow
The following slide deck was published by Biofrontera in conjunction with this Read more ...
Source: SeekingAlpha
Date: October, 31 2018 18:06
Biofrontera to present at the Baader Investment Conference
Leverkusen, Germany, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be participating at the Baader Investment Conference. The conference will take place from Sept...
Source: GlobeNewswire
Date: September, 19 2018 04:03
Correction of news release from August 31, 2018: Biofrontera reports significant revenue growth for the first 6 months of 2018
Leverkusen, Germany, Sept. 03, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its financial results for the six months ended June 30, 2018 and provided an upd...
Source: GlobeNewswire
Date: September, 03 2018 05:35
Biofrontera AG (BFRA) CEO Hermann Lübbert on Q2 2018 Results - Earnings Call Transcript
Biofrontera AG (BFRA) Q2 2018 Earnings Conference Call August 31, 2018 08:30 AM ET Executives Pamela Keck - Manager, Investor Relations Hermann Lübbert - Chief Executive Officer Thomas Schaffer - Chief Financial Officer Christoph Dünwald - Chief Commercial Officer ...
Source: SeekingAlpha
Date: August, 31 2018 13:25
Biofrontera reports 1H results
Biofrontera (NASDAQ: BFRA ): 1H GAAP EPS of -€0.18. More news on: Biofrontera, Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: August, 31 2018 08:28
Biofrontera 1H revenues up 80%
Biofrontera ( BFRA ) 1H results (€): Revenues: 9M (+80.0%); Net Loss: (8.1M) (+0.5%); Loss Per Share: (0.18) (+21.7%); Quick Assets: 26.3M (+136.9%); CF Ops: (6.8M) (+16.0%). More news on: Biofrontera, Healthcare stocks news, Earnings news and commentary, Read more ...
Source: SeekingAlpha
Date: August, 31 2018 08:28
Stocks To Watch: Any Privacy For Tesla?
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. During what's supposed to be a sleepy period of low-volume market activity amid the...
Source: SeekingAlpha
Date: August, 11 2018 09:07
Biofrontera files lawsuit against W.K.T. Zours, Deutsche Balaton AG and further defendants
Leverkusen, Germany, June 12, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced that it has filed a complaint in the United States District Court for the Southern D...
Source: GlobeNewswire
Date: June, 12 2018 08:00
Biofrontera reports Q1 results
Biofrontera (NASDAQ: BFRA ): Q1 EPS of -€0.08 More news on: Biofrontera, Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: May, 30 2018 08:03

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-0813.743313.6513.7913.622,916
2018-05-1713.7513.9413.9813.752,157

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-063475.0000Short
2018-11-3011100.0000Short
2018-11-29100100100.0000Short
2018-11-15101101100.0000Short
2018-11-0613030.3300Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BFRA.


About Biofrontera AG (NASDAQ: BFRA)

Logo for Biofrontera AG (NASDAQ: BFRA)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: BFRA)

      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: May, 07 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: May, 03 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: May, 03 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: April, 30 2018
      Annual and transition report of foreign private issuers under sections 13 or 15(d)
      Filing Type: 20-FFiling Source: edgar
      Filing Date: April, 30 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: April, 26 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: April, 19 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: April, 12 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: March, 28 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: March, 23 2018

       

       


      Daily Technical Chart for (NASDAQ: BFRA)

      Daily Technical Chart for (NASDAQ: BFRA)


      Stay tuned for daily updates and more on (NASDAQ: BFRA)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: BFRA)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BFRA is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of BFRA and does not buy, sell, or trade any shares of BFRA. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/